SVRA
Savara Inc.
stockNASDAQ
Market OpenOct 5, 2026 10:50:15 AM EDT
4.72USD-1.767%(-0.09)427,696
4.7200Bid4.7300Ask0.0100SpreadPre-marketOct 5, 2026 9:28:30 AM EDT
4.87USD+1.247%(+0.06)
Loading…
Loading…
970.80M
Healthcare
Biotechnology
CEO
Robert Neville
HQ
Austin, TX, USA
Previous Close
$4.84
Beta
1.32
52-Week High
$7.01 2025-12-12
52-Week Low
$3.34 2025-10-08
SMA 50
$5.38
SMA 200
$5.52
Avg. Vol 10D
2.87M
Avg. Vol 30D
1.92M
Avg. Vol 90D
1.86M
Relative Vol
0.20
205.46M
106.86M
52.01%
43,343,616
40.56%
36.25
58%/42%
50.89%
38.78%
0.4200%
250,000
3,065
1,297
6,577
Nov 11, 2026 (37d)
Apr 26, 2010 · 1-for-25 (reverse)
Sep 24, 2026
Notable Thursday Option Activity: SVRA, CAR, SPCX · 
BNK Invest
SVRA Profile
savara pharmaceuticals is an emerging specialty pharmaceutical company developing innovative pulmonary drugs for the treatment of serious and life-threatening conditions. the company's lead product, aerovanc is the first dry powder inhaled antibiotic for the treatment of methicillin-resistant staphylococcus aureus (mrsa) infection in patients with cystic fibrosis (cf). for more information, please see savara's website at www.savarapharma.com or www.aerovanc.com
SVRA Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 5.07 | 2026-09-28 | -6.80% | -6.028 |
| 1M | 5.37 | 2026-09-04 | -12.01% | 1.048 |
| 3M | 6.20 | 2026-07-06 | -23.79% | 0.668 |
| 6M | 5.60 | 2026-04-06 | -15.63% | 1.110 |
| 1Y | 3.46 | 2025-10-06 | +36.56% | 1.319 |
| 2Y | 3.82 | 2024-10-04 | +23.69% | — |
| 5Y | 1.30 | 2021-10-05 | +263.46% | 0.880 |
SVRA Stock Summary
Savara Inc. (NASDAQ:SVRA) stock price today is $4.73, and today's volume is 392,494. SVRA is down 1.767% today. The 30 day average volume is 1.92M. SVRA market cap is $970.80M with 205.46M shares outstanding.